Boston Scientific ROA 2006-2018 | BSX

Current and historical return on assets (ROA) values for Boston Scientific (BSX) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Boston Scientific ROA for the three months ending December 31, 2018 was 10.27%.
Boston Scientific ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-12-31 $1.67B $21.00B 8.33%
2018-09-30 $0.67B $20.38B 3.43%
2018-06-30 $0.52B $19.62B 2.72%
2018-03-31 $0.11B $19.20B 0.60%
2017-12-31 $0.10B $19.04B 0.56%
2017-09-30 $0.84B $18.64B 4.62%
2017-06-30 $0.79B $18.38B 4.37%
2017-03-31 $0.44B $17.94B 2.43%
2016-12-31 $0.35B $18.10B 1.95%
2016-09-30 $0.08B $17.70B 0.45%
2016-06-30 $-0.35B $17.84B -1.92%
2016-03-31 $-0.04B $17.72B -0.20%
2015-12-31 $-0.24B $18.13B -1.37%
2015-09-30 $-0.40B $18.22B -2.30%
2015-06-30 $-0.16B $17.12B -0.92%
2015-03-31 $-0.25B $16.47B -1.52%
2014-12-31 $-0.12B $17.02B -0.72%
2014-09-30 $0.29B $16.72B 1.74%
2014-06-30 $0.24B $16.48B 1.45%
2014-03-31 $0.37B $16.34B 2.19%
2013-12-31 $-0.12B $16.57B -0.72%
2013-09-30 $-0.17B $16.92B -0.99%
2013-06-30 $-0.83B $17.00B -4.88%
2013-03-31 $-4.54B $16.76B -26.43%
2012-12-31 $-4.07B $17.15B -22.27%
2012-09-30 $-4.02B $16.90B -20.84%
2012-06-30 $-3.22B $17.82B -15.73%
2012-03-31 $0.51B $21.19B 2.38%
2011-12-31 $0.44B $21.29B 2.04%
2011-09-30 $0.57B $21.50B 2.61%
2011-06-30 $0.62B $21.56B 2.80%
2011-03-31 $0.57B $22.07B 2.54%
2010-12-31 $-1.07B $22.13B -4.71%
2010-09-30 $-2.38B $22.49B -10.17%
2010-06-30 $-2.66B $23.02B -10.94%
2010-03-31 $-2.60B $22.85B -10.36%
2009-12-31 $-1.03B $25.18B -3.95%
2009-09-30 $-2.33B $26.23B -8.82%
2009-06-30 $-2.31B $26.19B -8.46%
2009-03-31 $-2.37B $26.11B -8.40%
2008-12-31 $-2.04B $27.14B -6.95%
2008-09-30 $-0.11B $29.83B -0.37%
2008-06-30 $-0.31B $29.90B -1.01%
2008-03-31 $-0.29B $30.35B -0.94%
2007-12-31 $-0.50B $31.20B -1.59%
2007-09-30 $0.24B $31.33B 0.77%
2007-06-30 $0.59B $31.27B 1.90%
2007-03-31 $-3.79B $31.07B -12.29%
2006-12-31 $-3.58B $30.88B -14.12%
2006-09-30 $-3.52B $30.75B -17.90%
2006-06-30 $-3.87B $30.61B -27.61%
2006-03-31 $0.60B $9.11B 7.20%
2005-12-31 $0.63B $8.20B 7.81%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $51.696B $9.823B
Boston Scientific Corporation transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader they advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $136.952B 27.07
Medtronic (MDT) Ireland $121.227B 17.72
Stryker (SYK) United States $72.547B 26.60
Baxter (BAX) United States $39.588B 25.33
Zimmer Biomet Holdings (ZBH) United States $25.898B 16.58
Smith & Nephew SNATS (SNN) United Kingdom $17.446B 0.00
Canopy Growth (CGC) Canada $14.852B 0.00
ResMed (RMD) United States $14.350B 27.21
Bio-Rad Laboratories (BIO) United States $9.156B 52.24
Aurora Cannabis (ACB) Canada $9.141B 64.50
Hill-Rom Holdings (HRC) United States $6.962B 21.53
Perrigo (PRGO) Ireland $6.420B 10.41
Insulet (PODD) United States $5.800B 1956.80
GW Pharmaceuticals (GWPH) United Kingdom $5.092B 0.00
ICU Medical (ICUI) United States $4.698B 29.24
Haemonetics (HAE) United States $4.311B 38.24
Hutchison China MediTech (HCM) China $3.810B 0.00
Agios Pharmaceuticals (AGIO) United States $3.637B 0.00
Neogen (NEOG) United States $3.108B 47.74
NuVasive (NUVA) United States $2.892B 25.23
Quidel (QDEL) United States $2.514B 22.68
Aphria (APHA) $2.385B 105.89
National Vision Holdings (EYE) United States $2.274B 44.72
Cardiovascular Systems (CSII) United States $1.346B 966.50
Phibro Animal Health (PAHC) United States $1.283B 18.45
VAREX IMAGING (VREX) United States $1.275B 24.96
AtriCure (ATRC) United States $1.081B 0.00
MacroGenics (MGNX) United States $0.926B 0.00
Lantheus Holdings (LNTH) United States $0.911B 24.60
Cerus (CERS) United States $0.844B 0.00
PetIQ (PETQ) United States $0.831B 23.77
Omeros (OMER) United States $0.828B 0.00
NanoString Technologies (NSTG) United States $0.729B 0.00
Meridian Bioscience (VIVO) United States $0.715B 21.30
OraSure Technologies (OSUR) United States $0.664B 29.11
Eagle Pharmaceuticals (EGRX) United States $0.657B 22.35
Evolus (EOLS) United States $0.655B 0.00
TG Therapeutics (TGTX) United States $0.601B 0.00
LeMaitre Vascular (LMAT) United States $0.596B 28.35
Surmodics (SRDX) United States $0.563B 81.90
Quanterix (QTRX) United States $0.518B 0.00
BioLife Solutions (BLFS) United States $0.364B 150.23
Vapotherm (VAPO) United States $0.335B 0.00
Rockwell Medical (RMTI) United States $0.331B 0.00
Insys Therapeutics (INSY) United States $0.328B 0.00
Utah Medical Products (UTMD) United States $0.300B 19.49
Owens & Minor (OMI) United States $0.271B 3.76
Bovie Medical (APYX) United States $0.260B 0.00
Cytosorbents (CTSO) United States $0.241B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.238B 0.00
Zynex (ZYXI) United States $0.145B 15.52
Fonar (FONR) United States $0.137B 7.33
Surface Oncology (SURF) United States $0.116B 0.00
Chimerix (CMRX) United States $0.102B 0.00
Female Health (VERU) United States $0.100B 0.00
Chembio Diagnostics (CEMI) United States $0.096B 0.00
United-Guardian (UG) United States $0.087B 19.84
CAS Medical Systems (CASM) United States $0.072B 0.00
Neurotrope (NTRP) United States $0.065B 0.00
Trinity Biotech (TRIB) Ireland $0.058B 17.14
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.039B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Valeritas Holdings (VLRX) United States $0.035B 0.00
Senestech (SNES) United States $0.029B 0.00
Capricor Therapeutics (CAPR) United States $0.018B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.016B 0.00
Akers Biosciences Inc (AKER) United States $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.008B 15.29